Presented by Marvin Xavierselvan, Ph.D. student in the integrated Biofunctional Imaging and Therapeutics Lab (iBIT) at Tufts University on January 25th, 2022.
The authors evaluate the potential of ultrasound to detect bone metastases in a rat model of metastatic breast cancer. They develop an automated 3D methodology to determine lesion morphology and perfusion, and validate these measurements with magnetic resonance imaging (MRI).
Here the authors report on the synthesis, characterization, and potential utility of ultra-small NaYF4:Nd3+/NaGdF4 nanocrystals coated with manganese dioxide (usNP-MnO2) for spatiotemporal modulation of hypoxia in head and neck squamous cell carcinomas.
In this recent study by Bachawal et al., authors used the multimodal imaging capabilities of the Vevo imaging system to evaluate the aggressiveness of ductal carcinoma in situ (DCIS) through B7-H3 targeted ultrasound and photoacoustic molecular imaging.
This recent article by Lavaud et al. uses high-frequency ultrasound and spectroscopic photoacoustic imaging (PAI), along with commercially available contrast agents to non-invasively examine metastatic liver lesions.
A conversation with Dr Florian Raes. He shares the development of an all-in-one multimodal imaging platform combining the Vevo LAZR’s ultrasound and photoacoustic capabilities with bioluminescence and near-infrared fluorescence.
In this study, Ramasawmy et al.1 sought to compare 9 Tesla (T) MRI, Benchtop (1T) MRI, Vevo US and BLI in the ability to monitor and detect tumor growth in a xenograft colorectal metastasis model in the mouse liver.
In this talk, recorded during the Innovation in Imaging Summit 2018 in Toronto, researcher Danielle Charron shares her lab's approach to creating photoacoustic nanoparticles. She highlights how a lot of the work they do in fluorescent imaging can also be done using photoacoustics as well.
